Krystal Biotech, Inc.
KRYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,111,073 | $3,973,969 | $5,195,345 | $4,504,758 |
| - Cash | $392,604 | $353,829 | $308,770 | $344,865 |
| + Debt | $1,698 | $1,617 | $9,662 | $7,261 |
| Enterprise Value | $4,720,167 | $3,621,757 | $4,896,237 | $4,167,154 |
| Revenue | $97,800 | $96,042 | $88,183 | $91,139 |
| % Growth | 1.8% | 8.9% | -3.2% | – |
| Gross Profit | $92,137 | $88,877 | $83,155 | $86,190 |
| % Margin | 94.2% | 92.5% | 94.3% | 94.6% |
| EBITDA | $49,576 | $40,850 | $37,811 | $42,934 |
| % Margin | 50.7% | 42.5% | 42.9% | 47.1% |
| Net Income | $79,365 | $38,333 | $35,733 | $45,479 |
| % Margin | 81.2% | 39.9% | 40.5% | 49.9% |
| EPS Diluted | 2.66 | 1.29 | 1.2 | 1.52 |
| % Growth | 106.2% | 7.5% | -21.1% | – |
| Operating Cash Flow | $39,659 | $52,729 | $30,969 | $52,843 |
| Capital Expenditures | -$1,704 | -$1,904 | -$6,204 | -$801 |
| Free Cash Flow | $37,955 | $50,825 | $24,765 | $52,042 |